Completed Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies NCT04681105 Conditions Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Burkitt Lymphoma, +58 more Locations City of Hope Medical Center — Duarte, California, United States View Trial Details
Active, Not Recruiting Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia NCT03834961 Conditions Central Nervous System Neoplasm, Central Nervous System Neoplasms, Infantile Fibrosarcoma, +7 more Locations Children's Hospital of Alabama — Birmingham, Alabama, United States Arkansas Children's Hospital — Little Rock, Arkansas, United States Kaiser Permanente Downey Medical Center — Downey, California, United States Children's Hospital Los Angeles — Los Angeles, California, United States View all 80 locations View more locations Show fewer locations Loading locations... View Trial Details
